Related Experiment Video
Updated: Sep 17, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Acute bronchiolitis: fundamentals of a rational protocol]
D González Caballero1, E González Pérez-Yarza
1Unidad de Neumología Infantil. Servicio de Pediatría. Hospital San Rafael. Madrid. lgcaballero@saludalia.com
Insights
Bronchiolitis, a common infant respiratory illness caused by viruses like respiratory syncytial virus, often lacks standardized treatment protocols. This review examines clinical scores and therapies, recommending inhaled adrenaline for moderate-to-severe cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Context:
- Bronchiolitis is the most common lower respiratory tract infection in infants under two.
- Viral infections, particularly respiratory syncytial virus, are the primary cause.
- Clinical management is challenged by inconsistent treatment guidelines and lack of standardized severity assessment tools.
Purpose:
- To review current medical literature on clinical severity scores for bronchiolitis.
- To evaluate the therapeutic efficacy of various pharmacological treatments for bronchiolitis.
- To provide a practical management protocol for pediatricians.
Summary:
- The study reviews literature on clinical scores and drug efficacy for bronchiolitis.
- It highlights the need for standardized diagnostic and treatment approaches.
- Inhaled adrenaline, oxygen, and fluid therapy are recommended for moderate-to-severe hospitalized cases.
Impact:
- Aims to improve the consistency and effectiveness of bronchiolitis management in clinical practice.
- Provides evidence-based recommendations for pediatricians facing treatment dilemmas.
- Contributes to better patient outcomes by standardizing care for this frequent childhood illness.
Abstract:
Bronchiolitis is the most frequent respiratory tract disease in the first 2 years of life. It occurs in epidemics in winter and spring. Etiology is viral and the most frequent causative agent is respiratory syncytial virus. In most patients the disease is benign and self-limiting and only occasionally requires hospitalization. In daily clinical practice, one of the problems most frequently faced by the pediatrician is the lack of agreement on the correct pharmacological treatment of bronchiolitis, as well as the absence of simple, or standardized, clinical scores with which to diagnose severity. The present study provides a review of the medical literature on the most commonly used clinical scores and the therapeutic efficacy of the different drugs employed. A protocol for the practical management of bronchiolitis is provided. The use of inhaled adrenaline in the treatment of moderate-to-severe bronchiolitis in hospitalized infants, as well as oxygen and fluid therapy as support measures, are recommended.
Related Concept Videos
01:17Pulmonary Cycle: Exhalation
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features